Recent News

• 12.11.2025 - OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
• 12.03.2025 - OKYO Pharma Announces Chairman and Founder Acquires Shares
• 11.21.2025 - OKYO Pharma Announces Chairman and Founder Acquires Shares
• 11.18.2025 - OKYO Pharma to Present at OIS XV in San Diego
• 10.29.2025 - OKYO Pharma to Present at BIO-Europe 2025 in Vienna
• 10.16.2025 - OKYO Pharma Announces Chairman and Founder Acquires Shares

Recent Filings

• 12.11.2025 - EX-99.1 EX-99.1
• 12.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.03.2025 - EX-99.1 EX-99.1
• 12.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.21.2025 - EX-99.1 EX-99.1
• 11.18.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.18.2025 - EX-99.1 EX-99.1
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors